title: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
authors.forename: Robert O
authors.initials: RO
authors.lastname: Bonow
authors.forename: Rick A
authors.initials: RA
authors.lastname: Nishimura
authors.forename: Paul D
authors.initials: PD
authors.lastname: Thompson
authors.forename: James E
authors.initials: JE
authors.lastname: Udelson
mesh_terms: D026683:Advisory Committees / Q000592:standards*; D000572:American Heart Association; D056352:Athletes; D002309:Cardiology / Q000379:methods / Q000592:standards*; D018376:Cardiovascular Abnormalities / Q000175:diagnosis* / Q000453:epidemiology; D006349:Heart Valve Diseases / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards; D014481:United States / Q000453:epidemiology
keywords: AHA Scientific Statements; athletes; cardiovascular abnormalities; valvular heart disease